The current leadership team at HLS Therapeutics has a wealth of experience in the pharmaceutical industry. The CEO has previously been an owner and CEO at Kingsbarn Ventures LLC, as well as the Chief Executive Officer at Duchesnay USA. The Executive Vice-President and Chief Operating Officer has previously worked at Biovail, and the President has previously worked at MDS Pharma Services. All three members of the leadership team have received an MBA from Concordia University, and the CEO and Executive Vice-President also have degrees in Mechanical Engineering from Université de Sherbrooke.
View all